ArticleMSMR2025
Exertional rhabdomyolysis among active component members of the U.S. Armed Forces, 2020-2024.
Article in MSMR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exertional rhabdomyolysis is a pathologic muscle breakdown associated with strenuous physical activity. A largely preventable condition, it persists as an occupational hazard of military training and operations, especially in high heat environments among individuals pushing their endurance limits. A total of 464 cases of exertional rhabdomyolysis were identified in 2024, corresponding to a crude incidence rate of 35.9 cases per 100,000 person-years, and is the lowest case count recorded during the 2020-2024 period of surveillance. The 2024 case numbers demonstrated a 9.6% reduction from the peak rate in 2023, and the proportion of 39.7% hospitalized in 2024 represented a 4.0% decrease from 2023. In 2024, all services, excepting the Navy, showed declines in incidence rates, ranging from 2.0% in the Coast Guard to 29.1% in the Air Force, compared to 2023. Consistent with prior reports, subgroup-specific crude rates in 2024 were highest among men, those less than 20 years old, non-Hispanic Black service members, Marine Corps or Army members, and those in combat-specific or 'other' military occupations. Recruit trainees continued to experience the highest rates of exertional rhabdomyolysis in 2024, with a rate more than 13 times greater than officers and enlisted members. During the 2020-2024 surveillance period, 2024 evinced the lowest incidence rate of exertional rhabdomyolysis, nearly 10% lower than the peak observed in 2023. The Air Force showed the largest reduction, with incidence rates decreasing approximately 30% from the previous year.
Indexed as
Identifiers
40591365PMC12266732What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.